KLK3 and prostate cancer: To infer the mortality benefit of early detection of prostate cancer reported in ERSPC, the sensitivity to detect high-grade disease needs to be at least as high as when performing systematic prostate biopsies with a PSA cut-off of 3 ng/ml, being the threshold primarily used for biopsy in ERSPC [5].